Tsvelev Iu V, Khavinson V Kh, Diachuk A V, Gur'ev A V, Seryĭ S V
Akush Ginekol (Mosk). 1992 Feb(2):54-7.
Thymogen, a new immunomodulating drug made in this country, was used in combined therapy of 46 patients with acute endomyometritis, exacerbations of chronic salpingo-oophoritis, purulent tubo-ovarian formations. Thymogen therapy was conducive to normalization of lymphocyte counts, absolute counts of T and B lymphocytes, increase of T lymphocyte functional activity. The drug is characterized by a desensitizing effect and induces no complications. Marked clinical effect recommends the immunomodulator thymogen for combined therapy of patients with inflammatory diseases of the uterus and its appendages.
胸腺生成素，一种本国生产的新型免疫调节药物，被用于46例急性子宫内膜炎、慢性输卵管卵巢炎急性发作、化脓性输卵管卵巢肿物患者的联合治疗。胸腺生成素治疗有助于淋巴细胞计数、T淋巴细胞和B淋巴细胞绝对计数恢复正常，增强T淋巴细胞功能活性。该药物具有脱敏作用且不会引发并发症。显著的临床疗效表明免疫调节剂胸腺生成素可用于子宫及其附件炎性疾病患者的联合治疗。
